Advertisement

Loading...

GABY Inc.

GABY.CNCNQ
Healthcare
Medical - Pharmaceuticals
$0.005
$0.00(0.00%)
Canadian Market is Open • 15:38

GABY Inc. Fundamental Analysis

GABY Inc. (GABY.CN) shows weak financial fundamentals with a PE ratio of -0.09, profit margin of -1.34%, and ROE of 2.91%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position38.24%
PEG Ratio-0.00

Areas of Concern

ROE2.91%
Operating Margin-7.29%
Current Ratio0.16
We analyze GABY.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -58.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-58.3/100

We analyze GABY.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

GABY.CN struggles to generate sufficient returns from assets.

ROA > 10%
-1.30%

Valuation Score

Excellent

GABY.CN trades at attractive valuation levels.

PE < 25
-0.09
PEG Ratio < 2
-0.00

Growth Score

Weak

GABY.CN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

GABY.CN shows balanced financial health with some risks.

Debt/Equity < 1
-1.33
Current Ratio > 1
0.16

Profitability Score

Moderate

GABY.CN maintains healthy but balanced margins.

ROE > 15%
290.62%
Net Margin ≥ 15%
-1.34%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is GABY.CN Expensive or Cheap?

P/E Ratio

GABY.CN trades at -0.09 times earnings. This suggests potential undervaluation.

-0.09

PEG Ratio

When adjusting for growth, GABY.CN's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values GABY Inc. at -0.11 times its book value. This may indicate undervaluation.

-0.11

EV/EBITDA

Enterprise value stands at 1.16 times EBITDA. This is generally considered low.

1.16

How Well Does GABY.CN Make Money?

Net Profit Margin

For every $100 in sales, GABY Inc. keeps $-1.34 as profit after all expenses.

-1.34%

Operating Margin

Core operations generate -7.29 in profit for every $100 in revenue, before interest and taxes.

-7.29%

ROE

Management delivers $2.91 in profit for every $100 of shareholder equity.

2.91%

ROA

GABY Inc. generates $-1.30 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.30%

Following the Money - Real Cash Generation

Operating Cash Flow

GABY Inc. generates limited operating cash flow of $1.16M, signaling weaker underlying cash strength.

$1.16M

Free Cash Flow

GABY Inc. produces free cash flow of $1.09M, offering steady but limited capital for shareholder returns and expansion.

$1.09M

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

GABY.CN converts 39.84% of its market value into free cash.

39.84%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.09

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.11

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.12

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.33

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.16

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

2.91

vs 25 benchmark

ROA

Return on assets percentage

-1.30

vs 25 benchmark

ROCE

Return on capital employed

-0.24

vs 25 benchmark

How GABY.CN Stacks Against Its Sector Peers

MetricGABY.CN ValueSector AveragePerformance
P/E Ratio-0.0927.91 Better (Cheaper)
ROE290.62%687.00% Weak
Net Margin-134.36%-45285.00% (disorted) Weak
Debt/Equity-1.330.33 Strong (Low Leverage)
Current Ratio0.162795.76 Weak Liquidity
ROA-130.48%-13557.00% (disorted) Weak

GABY.CN outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews GABY Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ